Dean L. Schorno
Overview
Dean L. Schorno received an average of $1M in total compensation, including $358K in salary, at Rigel Pharmaceuticals from 2018 to 2020. Dean Schorno also received an average of $899K at Genomic Health from 2011 to 2014.
- 2020
- 2019
- 2018
- 2014
- 2013
- 2012
- 2011
Rigel PharmaceuticalsExecutive Vice President and Chief Financial Officer
Rigel PharmaceuticalsExecutive Vice President and Chief Financial Officer
Rigel PharmaceuticalsExecutive Vice President and Chief Financial Officer
Genomic HealthChief Financial Officer
Genomic HealthChief Financial Officer
Genomic HealthChief Financial Officer
Genomic HealthChief Financial Officer
Source: SEC filings on April 6, 2021, April 1, 2020, April 9, 2019, April 30, 2015, and April 26, 2012.
Related executives
We found 19 more executives who work or worked at Rigel Pharmaceuticals and Genomic Health.
Raul Rodriguez
Rigel Pharmaceuticals
Chief Executive Officer
Dolly Vance
Rigel Pharmaceuticals
Executive Vice President, Corporate Affairs, General
David Santos
Rigel Pharmaceuticals
Executive Vice President and Chief Commercial Officer
Wolfgang Dummer
Rigel Pharmaceuticals
Chief Medical Officer
Anne-Marie Duliege
Rigel Pharmaceuticals
Chief Medical Officer
Eldon Mayer
Rigel Pharmaceuticals
Executive Vice President, Chief Commercial Officer
Esteban Masuda
Rigel Pharmaceuticals
Executive Vice President, Research
Kimberly Popovits
Genomic Health